In this work the authors identify a novel inhibitor of alginate overproduction in Pseudomonas aeruginosa which is an interesting finding that will be of importance to the field of bacterial pathogenesis. 
Alginate overproduction is a key mechanism for the development of a chronic lung infection by P. aeruginosa in individuals with cystic fibrosis (Govan & Deretic, 1996) . Alginate overproduction is achieved through increased transcription of the alginate biosynthetic operon at the algD promoter (Deretic et al., 1987) . Regulation of alginate overproduction primarily involves the alternative sigma factor AlgU (AlgT, r 22 ) and its cognate antisigma factor, MucA (Martin et al., 1993a, b) . Typically, in low-alginate-producing P. aeruginosa strains, AlgU is sequestered by MucA to the inner membrane (Mathee et al., 1997; Rowen & Deretic, 2000) . However, with a loss of MucA through mutations, AlgU is free to activate transcription at the algD promoter (Martin et al., 1993a, b; Wozniak & Ohman, 1994) . Previous reports have also determined an alternative mechanism for alginate overproduction, which requires AlgW, a DegS-like serine protease (Wood et al., 2006; Qiu et al., 2007; Cezairliyan & Sauer, 2009) . AlgW is the first intramembrane protease that has been shown to degrade the periplasmic portion of MucA (Cezairliyan & Sauer, 2009) . However, there are other proteases, MucP and ClpXP that are also required for alginate overproduction via the degradation of MucA (Qiu et al., 2007 (Qiu et al., , 2008a . All of these proteases regulate alginate production by degrading MucA. Additionally, it has been suggested that preventing the overproduction of alginate (Ramsey & Wozniak, 2005) , and more specifically inhibiting the regulated proteolytic degradation of MucA (Damron & Goldberg, 2012) , is a potential strategy to prevent the establishment of chronic P. aeruginosa infections. In response to these suggestions, we employed whole-genome complementation coupled with in vitro transposon mutagenesis to identify a genetic locus that can inhibit alginate overproduction in P. aeruginosa strains with a wild-type mucA.
Recently, we determined that alginate overproduction in P. aeruginosa strain PAO579 (muc-23), a derivative of PAO1, is caused by the release of AlgU from MucA via regulated intramembrane proteolysis (Withers et al., 2012 (Withers et al., , 2013 . This proteolytic cascade is initiated by the activation of AlgW through a truncated type-IV pilus (PilA108; Withers et al., 2013) . To identify novel inhibitors of alginate overproduction in P. aeruginosa strains with a wild-type mucA, a PAO1-derived, minimal tiling path (MTP) genomic cosmid library (Huang et al., 2000) was conjugated into PAO579 (Govan & Fyfe, 1978) . As a result, we identified that cosmid MTP87 could completely suppress alginate overproduction in PAO579 (data not shown). MTP87 covers a region of 22,757 bp from the genome of PAO1 (start: 1,618,021; and end: 1,640,777) . To identify the exact gene within this cosmid responsible for the multicopy suppression of alginate overproduction, MTP87 underwent random transposon-mediated in vitro mutagenesis, and the mutated cosmids were then conjugated en masse into PAO579 and screened for alginate overproduction (Fig. 1a) . We observed the presence of alginate-overproducing clones, indicating a transposon-mediated inactivation of a specific inhibitory gene within cosmid MTP87 (Fig. 1a) . PCR and sequence analysis of the mutagenized MTP87 confirmed a single transposon insertion in open reading frame PA1494. Previous transcriptome analyses have shown that PA1494 is up-regulated when P. aeruginosa is exposed to azithromycin (Nalca et al., 2006; Kai et al., 2009 ) and hydrogen peroxide (Chang et al., 2005) . However, because PA1494 belongs to a class of unclassified/hypothetical genes and its Rhodobacter capsulatus (RC; ORF1654; 534aa), Bradyrhizobium japonicum (BJ; CAC38742; 560aa), Nostoc sp. (NOS; NP_484904; 545aa), and Caenorhabditis elegans (CE; NP_500427; 556aa). A single Tn insertion occurred before regions 1, 2, and 3. (c) PAO1 pHERD20T, PAO579 pHERD20T (vector control), PAO579 pHERD20T-muiA (wild-type muiA), and PAO579 pHERD20T-muiADN22 (deletion of N-terminal signal sequence) were grown on PIA plates supplemented with carbenicillin and 0.1% arabinose for 24 h at 37°C and then for 24 h at room temperature. The alginate was collected and measured using the standard carbazole assay. The values are representative of three independent experiments. Statistical significance was determined using the Student's t-test in comparison with PAO579 (*P < 0.05). (d) The b-galactosidase activity of the algD promoter was measured using PAO1 and PAO579 miniCTX-P algD -lacZ with pHERD20T, pHERD20T-muiA, or pHERD20T-muiADN22. All strains were incubated at 37°C on PIA plates supplemented with tetracycline, carbenicillin, and 0.1% arabinose. The values for the mean and standard deviation in Miller units (one Miller unit = 1000 9 (A 420 /À1.75 9 A 550 /OD 600 nm mL À1 min À1 )) are shown as relative expression as compared to PAO1 and are representative of three independent experiments. Statistical significance was determined using the Student's t-test in comparison with PAO579 (*P < 0.05). (e) Alginate measurements for various laboratory and clinical strains expressing pHERD20T (vector control) or pHERD20T-muiA in trans. Strains were cultured on PIA plates supplemented with 300 lg mL À1 of carbenicillin and 0.1% arabinose and incubated for 24 h at 37°C and then for 24 h at room temperature. The values are representative of three independent experiments. Statistical significance was determined using the Student's t-test in comparison with the vector control (*P < 0.05).
exact function is unknown, we refer to PA1494 as mucoidy inhibitor gene A or muiA. The muiA gene is predicted to encode a polypeptide of 551 amino acids with a predicted molecular mass of 61 kDa and an isoelectric point (pI) of 5.5. Located immediately downstream is the E. coli periplasmic sulfate-binding ortholog (cysP: PA1493). The muiA gene is predicted to use GTG as a start codon with a typical type-I signal sequence encoding 22 amino acids (NH 2 -MNRLAASPLLFAGLFA-SAPLLA-COOH; Lewenza et al., 2005) , and previous proteomic analysis detected MuiA in the periplasm of PAO1. Based on MALDI-TOF/TOF survey on the proteome of the PAO1 cell envelope, the relative abundance of MuiA was in the same range as the alginate negative regulator MucB, but less than the major porin protein OprF (Imperi et al., 2009) . Additionally, we confirmed the results presented in the previous studies by detecting the presence of a hemagglutinin-tagged MuiA in the periplasm using cell fractionation and Western blot analysis (data not shown). Through BLAST analysis, we determined that MuiA is highly conserved among other P. aeruginosa strains; however, no orthologs were identified in E. coli species or other Pseudomonads. MuiA orthologs were found in other organisms including Rhodobacter capsulatus, Bradyrhizobium japonicum, Nostoc sp., and Caenorhabditis elegans (Fig. 1b) . These orthologs are all of similar size ranging from 530 to 560 amino acids in length and are classified as conserved hypothetical proteins. An internal region of MuiA (232-274aa) displayed three highly conserved regions. In addition, the transposon insertion in MTP87 was located 15 bps in front of these conserved domains (Fig. 1b) .
To confirm whether muiA is responsible for suppressing alginate overproduction, we used standard molecular techniques (Russell, 2001) to clone muiA into the shuttle vector pHERD20T, which contains the P BAD arabinose-inducible promoter (Qiu et al., 2008b) . PAO1 pHERD20T, PAO579 pHERD20T (vector control), and PAO579 pHERD20T-muiA were cultured on PIA supplemented with carbenicillin and 0.1% arabinose, and the amount of alginate was measured using the standard carbazole assay (Knutson & Jeanes, 1968) . When compared to PAO1 and the vector control, there was a decrease in alginate overproduction when muiA was expressed in trans (Fig. 1c) . Additionally, we observed that pHERD20T-muiA can suppress mucoidy even in the absence of arabinose on PIA, suggesting that the basal expression from pHERD20T-muiA was sufficient for suppression (data not shown). We also observe that the removal of the N-terminal signal sequence (pHERD20T-muiADN22) abrogated MuiA's ability to suppress alginate overproduction in PAO579 (Fig. 1c) . Also, we observed that the in-frame deletion of muiA in strain PAO1 did not result in alginate overproduction, suggesting that MuiA does not play a central role in alginate regulation (data not shown). These results suggest that MuiA suppresses alginate overproduction after localization to the periplasm, and can act as a multicopy suppressor for alginate overproduction in PAO579.
Previously, it was reported that alginate overproduction in PAO579 was due to increased transcriptional activity at the P algD promoter site of the alginate biosynthetic operon (Boucher et al., 2000; Withers et al., 2013) . To determine the effect that the expression of muiA has on P algD activity, we used PAO1 and PAO579 merodiploid strains carrying a chromosomal copy of the algD promoter fused with a reporter gene, lacZ (generated via miniCTX-PalgD-lacZ). Next, we conjugated pHERD20T (vector control), pHERD20T-muiA, and pHERD20T-muiADN22 into the PAO1 or PAO579 miniCTX-P algD -lacZ and cultured them on PIA plates supplemented with carbenicillin, tetracycline, and 0.1% arabinose. We measured the transcriptional activity of P algD promoter using the Miller assay (Miller, 1972) . As expected, the level of transcriptional activity in PAO579 pHERD20T was significantly higher than that in PAO1 (Fig. 1d) . The activity at P algD decreased when pHERD20T-muiA was expressed in trans in PAO579 (Fig. 1d) . Additionally, we observed that expression of pHERD20T-muiADN22 did not result in a decrease in P algD activity in PAO579 (Fig. 1d) . Based on these results, we concluded that expression of muiA suppresses transcriptional activity at the alginate biosynthetic operon at the algD promoter.
To determine the overall robustness and to elucidate the possible mechanism by which MuiA suppresses alginate overproduction, we conjugated pHERD20T-muiA into a variety of laboratory and clinical strains. We observed that expression of muiA in trans suppressed alginate overproduction in PAO1-VE2 (Fig. 1e) . PAO1-VE2 is a derivative of PAO1 and overproduces alginate due to the activation of AlgW by MucE, a small envelope protein (Qiu et al., 2007; Cezairliyan & Sauer, 2009) . Similarly, expression of muiA in trans was able to suppress alginate overproduction in clinical strains C7447m and C4700m, both possessing a wild-type MucA (Fig. 1e) . The decrease in alginate overproduction observed in PAO1-VE2, C7447m, and C4700m was statistically significant when compared to the vector control (P < 0.05). However, expression of muiA was unable to suppress alginate overproduction in the PAO1-derived mucA25 strain, PAO581 (Fig. 1e ). PAO581 carries a truncated MucA25 protein, which lacks the transmembrane domain of the wild-type MucA, suggesting that MucA25 is likely localized in the cytoplasm (Qiu et al., 2008a) . Additionally, expression of muiA did not suppress alginate overproduction in the strain PDO300 (Fig. 1e) . PDO300 carries a truncated MucA22 protein. It is important to note that none of the strains examined in this study, aside from PAO579, have three tandem mutations resulting in a truncation of type-IV pili. Therefore, the suppression of alginate overproduction through the expression of MuiA is not specific to those strains possessing a truncation in type-IV pili. Together, these data suggest that MuiA's ability to suppress alginate overproduction is not unique to PAO579. However it is only effective at suppressing alginate overproduction in strains with a wild-type MucA.
In summary, we coupled whole-genome complementation of a PAO1 cosmid library and in vitro transposon mutagenesis to identify the genetic locus PA1494 (muiA) as a novel inhibitor of alginate overproduction in P. aeruginosa strains with a wild-type mucA. Additionally, we determined that expression of muiA in trans resulted in a decrease in alginate production, as well as transcriptional activity at the P algD promoter. Lastly, expression of muiA in trans was only able to suppress alginate overproduction in various clinical and laboratory strains possessing a wild-type MucA.
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